Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA-binding capacity

Journal of Cellular Physiology

Volumn 214, Issue 3, 2008, Pages 568-581

  Scimè, Anthony ^a,b   Li, Lili ^a   Ciavarra, Gianni ^a   Whyte, Peter ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; PROTEIN; PROTEIN DP1; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR E2F5; UNCLASSIFIED DRUG; DNA; TRANSCRIPTION FACTOR DP1;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL STRAIN 3T3; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REPORTER GENE; ANIMAL; CELL LINE; DRUG ANTAGONISM; INSECT; METABOLISM; MOUSE; PHOSPHORYLATION; PROTEIN BINDING; TRANSACTIVATION;

3T3-L1 CELLS; ANIMALS; CELL LINE; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; DNA; E2F4 TRANSCRIPTION FACTOR; E2F5 TRANSCRIPTION FACTOR; HUMANS; INSECTS; MICE; PHOSPHORYLATION; PROTEIN BINDING; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR DP1;

EID: 38449093030     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21243     Document Type: Article

References (94)

1. Apostolova MD, Ivanova IA, Dagnino C, D'Souza SJ, Dagnino L. 2002. Active nuclear import and export pathways regulate E2F5 subcellular localization. J Biol Chem 277:34471-34479.
2. Araki K, Nakajima Y, Eto K, Ikeda MA. 2003. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter. Oncogene 22:7632-7641.
3. Attwooll C, Lazzerini Denchi E, Helin K. 2004. The E2F family: Specific functions and overlapping interests. EMBO J 23:4709-4716.
4. Balciunaite E, Spektor A, Lents NH, Cam H, Te Riele H, Scime A, Rudnicki MA, Young R, Dynlacht BD. 2005. Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells. Mol Cell Biol 25:8166-8178.
5. Beijersbergen RL, Kerkhoven RM, Zhu L, Carlee L, Voorhoeve PM, Bernards R. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev 8:2680-2690.
6. Beijersbergen RL, Carlee L, Kerkhoven RM, Bernards R. 1995. Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev 9:1340-1353.
7. Bienvenue F, Gascan H, Coqueret O. 2001. Cyclin D1 represses STAT3 activation through a cdk4-independent mechanism. J Biol Chem 276:16840-16847.
8. Buck V, Allen EK, Sorensen T, Bybee A, Hijmans ME, Voorhoeve M, Bernards R, LaThangue NB. 1995. Molecular and functional characterization of E2F5, a new member of the E2F family. Oncogene 11:31-38.
9. Calbo J, Parreno M, Sotillo E, Yong T, Mazo A, Garriga J, Grana X. 2002. G1 cyclin cdk coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2 F1. J Biol Chem 277:50263-50274.
10. Cam H, Balciunaite E, Blais A, Spektor A, Scarpulla RC, Young R, Kluger Y, Dynlacht BD. 2004. A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell 16:399-411.
11. Cartwright P, Muller H, Wagener C, Holm K, Helin K. 1998. E2F-6: A novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 17:611-623.
12. Cobrinik D. 2005. Pocket proteins and cell cycle control. Oncogene 24:2796-2809.
13. Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev 7:2392-2404.
14. de Bruin A, Maiti B, Jakoi L, Timmers C, Buerki R, Leone G. 2003. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation. J Biol Chem 278:42041-42049.
15. De Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S. 1987. Firefly luciferase gene: Structure and expression in mammalian cells. Mol Cell Biol 7:725-737.
16. Di Stefano L, Jensen MR, Helin K. 2003. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J 22:6289-6298.
17. Dimova DK, Dyson NJ. 2005. The E2F transcriptional network: Old acquaintances with new faces. Oncogene 24:2810-2826.
18. Dong F, Cress DWJ, Agrawal D, Pledger WJ. 1998. The role of cyclin D3-dependent kinase in the phosphorylation of p130 in mouse BALB/c 3T3 fibroblasts. J Biol Chem 273:6190-6195.
19. Dowdy SF, Hinds PH, Louie K, Reed SI, Arnold A, Weinberg RA. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511.
20. Dynlacht BD, Flores O, Lees JA, Harlow E. 1994. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev 8:1772-1786.
21. Dyson N. 1998. The regulation of E2F by pRB family proteins. Genes Dev 12:2245-2262.
22. Ewen ME, Sluss HK, Sherr CJ, Matsuhime H, Kato J-Y, Livingston DM. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
23. Ezhevsky SA, Ho A, Becker-Hapak M, Davis PK, Dowdy SF. 2001. Differential regulation of retinoblastoma tumor suppressor protein by G1 cyclin-dependent kinase complexes in vivo. Mol Cell Biol 21:4773-4784.
24. Farkas T, Hansen K, Holm K, Lukas J, Bartek J. 2002. Distinct phosphorylation events regulate p130- and p107-mediated repression of E2 F4. J Biol Chem 277:26741-26752.
25. Ganter B, Fu S, Lipsick JS. 1998. D-type cyclins repress transcriptional activation by the v-myb but not the c-myb DNA-binding domain. EMBO J 17:255-268.
26. Gaubatz S, Wood JG, Livingston DM. 1998. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc Natl Acad Sci USA 95:9190-9195.
27. Gaubatz S, Lees JA, Lindeman GJ, Livingston DM. 2001. E2F4 is exported from the nucleus in a CRM1-dependent manner. Mol Cell Biol 21:1384-1392.
28. Ginsberg D, Vairo G, Chittenden T, Xiao Z-X, Xu G, Wydner KL, DeCaprio JA, Lawrence JB, Livingston DM. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev 8:2665-2679.
29. Graham FL, Van Der Eb AJ. 1973. A new technique for the assay of infectivity of human adenovirus. Virology 52:456-467.
30. Hansen K, Farkas T, Lukas J, Holm K, Ronnstrand L, Bartek J. 2001. Phosphorylation-dependent and -independent function of p130 cooperate to evoke a sustained G1 block. EMBO J 20:422-432.
31. Harbour JW, Luo RX, Santi AD, Postigo AA, Dean DC. 1999. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98:859-869.
32. Harlow E, Whyte P, Franza BRJ, Schley C. 1986. Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol Cell Biol 6:1579-1589.
33. He Y, Armanious MK, Thomas MJ, Cress WD. 2000. Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region. Oncogene 19:3422-3433.
34. Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A. 1992. A cDNA encoding a pRb-binding protein with properties of the transcription factor E2F. Cell 70:337-350.
35. Helin K, Wu C-L, Fattaey AR, Lees JA, Dynlacht BD, Ngwu C, Harlow E. 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev 7:1850-1861.
36. Hijmans EM, Voorhoeve PM, Beijersbergen RL, van't Veer LJ, Bernards R. 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol Cell Biol 15:3082-3089.
37. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
38. Hiyama H, Iavarone A, Reeves SA. 1998. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene 16:1513-1523.
39. Hsiao K-M, McMahon SL, Farnham PJ. 1994. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev 8:1526-1537.
40. Inoue K, Sherr CJ. 1998. Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism. Mol Cell Biol 18:1590-1600.
41. Ivey-Hoyle M, Conroy R, Huber HE, Goodhart PJ, Oliff A, Heimbrook DC. 1993. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol Cell Biol 13:7802-7812.
42. Johnson DG. 1995. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene 11:1685-1692.
43. Johnson DG, Ohtani K, Nevins JR. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 8:1514-1525.
44. Kaelin WG, Krek W, Sellers WR, DeCaprio JA, Ajchenbaum F, Fuchs CS, Chittenden T, Li Y, Farnham PJ, Blanar MA, Livingston DM, Flemington EK. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351-364.
45. Karlseder J, Rotheneder H, Wintersberger E. 1996. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol 16:1659-1667.
46. Kato J, Mitsushime H, Heibert SW, Ewen ME, Sherr CJ. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase C DK4. Genes Dev 7:331-342.
47. Kitagawa M, Higashi H, Suzuki-Takahashi I, Segawa K, Hanks SK, Taya Y, Nishimura S, Okuyama A. 1995. Phosphorylation of E2F-1 by cyclin A cdk2. Oncogene 10:229-236.
48. Knudsen KE, Cavenee WK, Arden KC. 1999. D type cyclins complex with the androgen receptor and inhibit its transcriptional transactivation ability. Cancer Res 59:2297-2301.
49. Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin WGJ, Livingston DM. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161-172.
50. Lacy S, Whyte P. 1997. Identification of a region of p130 mediating interactions with cyclin A/cdk2 and cyclin E/cdk2 complexes. Oncogene 14:2395-2406.
51. Lamb J, Ramaswamy S, Ford HL, Contreras B, Martinez RV, Kittrell FS, Zahnow CA, Patterson N, Golub TR, Ewen ME. 2003. A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114:323-334.
52. LeCam L, Polanowskaj, Fabbrizio E, Olivier M, Philips A, Eaton EN, Classon M, Geng Y, Sardet C. 1999. Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. EMBO J 18:1878-1890.
53. Lees J, Saito M, Vidal M, Valentine M, Look T, Harlow E, Dyson N, Helin K. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol Cell Biol 13:7813-7825.
54. Leng X, Noble M, Adams PD, Qin J, Harper JW. 2002. Reversal of growth suppression by p107 via direct phosphorylation by cyclin D1/cyclin dependent kinase 4. Mol Cell Biol 22:2242-2254.
55. Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams SR, Nevins J. 1998. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev 12:2120-2130.
56. Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L, Miron A, Nevins JR. 2000. Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins. Mol Cell Biol 20:3626-3632.
57. Li Y, Graham C, Lacy S, Duncan AMV, Whyte P. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7:2366-2377.
58. Lin X, Gelman IH. 2002. Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS. Biochem Biophys Res Commun 290:1368-1375.
59. Lindeman GJ, Gaubatz S, Livingston DM, Ginsberg D. 1997. The subcellular localization of E2F4 is cell cycle dependent. Proc Natl Acad Sci USA 94:5095-5100.
60. Logan N, Delavaine L, Graham A, Reilly C, Wilson J, Brummelkamp TR, Hijmans EM, Bernards R, La Thangue NB. 2004. E2F-7: A distinctive E2F family member with an unusual organization of DNA-binding domains. Oncogene 23:5138-5150.
61. Logan N, Graham A, Zhao X, Fisher R, Maiti B, Leone G, La Thangue NB. 2005. E2F-8: An E2F family member with a similar organization of DNA-binding domains to E2F-7. Oncogene 24:5000-5004.
62. Lundberg AS, Weinberg RA. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18:753-761.
63. Magae J, Wu C-L, Illenye S, Harlow E, Heintz NH. 1996. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J Cell Sci 109:1717-1726.
64. Maiti B, Li J, de Bruin A, Gordon F, Timmers C, Opavsky R, Patil K, Tuttle J, Cleghorn W, Leone G. 2005. Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation. J Biol Chem 280:18211-18220.
65. Matsushime H, Ewen ME, Strom DK, Kato J-Y, Hanks SK, Roussel MF, Sherr CJ. 1992. Identification and properties of an atypical catalytic subunit (p34psk-j3/cdk4) for mammalian D type G1 cyclins. Cell 71:323-334.
66. Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F. 2004. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430:226-231.
67. Mayol X, Garriga J, Grana X. 1995. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 11:801-808.
68. Moberg K, Startz MA, Lees JA. 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol 16:1436-1449.
69. Morkel M, Wenkel J, Bannister AJ, Kouzarides T, Hagemeier C. 1997. An E2F-like repressor of transcription. Nature 390:567-568.
70. Muller H, Moroni MC, Vigo E, Petersen BO, Bartek J, Helin K. 1997. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol Cell Biol 17:5508-5520.
71. Neuman E, Ladha MH, Lin L, Upton T, Miller SJ, DiRenzo J, Pestell RG, Hinds PW, Dowdy SF, Brown M, Ewen ME. 1997. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 17:5338-5347.
72. Nevins JR. 1998. Toward an understanding of the functional complexities of the E2F and retinoblastoma families. Cell Gowth Differ 9:585-593.
73. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y. 2002. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science 296:1132-1136.
74. Ohtani K, DeGregori J, Nevins JR. 1995. Regulation of the cyclin E gene by transcription factor E2 F1. Proc Natl Acad Sci USA 92:12146-12150.
75. Ohtani K, DeGregori J, Leone G, Herendeen DR, Kelly TJ, Nevins JR. 1996. Expression of the HsOrc1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor. Mol Cell Biol 16:6977-6984.
76. Ren B, Cam H, Takahashi Y, Violkert T, Terragni J, Young RA, Dynlacht B. 2002. E2F integrates cell cycle progression with DNA repair, replication and G2/M checkpoints. Genes Dev 16:245-256.
77. Sears R, Ohtani K, Nevins JR. 1997. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to growth signals. Mol Cell Biol 17:5227-5235.
78. Sherr CJ, Roberts JM. 2004. Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18:2699-2711.
79. Sleigh MJ. 1986. A nonchromatographic assay for expression of chloramphenicol acetyltransferase gene in eukaryotic cells. Anal Biochem 156:251-256.
80. Smith EJ, Leone G, DeGregori J, Jakoi L, Nevins JR. 1996. The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state. Mol Cell Biol 16:6965-6976.
81. Takahashi T, Rayman JB, Dynlacht BD. 2000. Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression. Genes Dev 14:804-816.
82. Tommasi S, Pfeifer GP. 1995. In vivo structure of the human cdc2 promoter: Release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol Cell Biol 15:6901-6913.
83. Tommasi S, Pfeifer GP. 1997. Constitutive protective of E2F recognition sequences in the human thymidine kinase promoter during cell cycle progression. J Biol Chem 272:30483-30490.
84. Trimarchi JM, Fairchild B, Verona R, Moberg K, Andon N, Lees JA. 1998. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc Natl Acad Sci USA 95:2850-2855.
85. Trimarchi JM, Fairchild B, Wen J, Lees JA. 2001. The E2F6 transcription factor is a component of the mammalian Bmi-1-containing polycomb complex. Proc Natl Acad Sci USA 98:1519-1524.
86. van den Heuvel S, Harlow E. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2053.
87. Verona R, Moberg K, Estes S, Starz M, Vernon JP, Lees JA. 1997. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol Cell Biol 17:7268-7282.
88. Voit R, Hoffman M, Grunnt I. 1999. Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF. EMBO J 18:1891-1899.
89. Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Hengelin B, Pestell R. 1998. Inhibitionof cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol 18:3212-3222.
90. Wells J, Boyd KE, Fry CJ, Bartley SM, Farnham PJ. 2000. Target gene specificity of E2F and pocket protein family members in living cells. Mol Cell Biol 20:5797-5807.
91. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML, Leone G. 2001. The E2F 1-3transcription factors are essential for cellular proliferation. Nature 414:457-462.
92. Xu M, Sheppard K, Peng CY, Yee AS, Piwinica-Worms H. 1994. Cyclin A/cdk2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol 14:8420-8431.
93. Zwicker J, Liu N, Engeland K, Lucibello FC, Muller R. 1996. Cell cycle regulation of E2F site occupation in vivo. Science 271:1595-1597.
94. Zwijsen RML, Buckle RS, Hijmans EM, Loomans CJM, Bernards R. 1998. Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev 12:3488-3498.